Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene

Published:1987-01-09 Issue:4785 Volume:235 Page:177-182
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Slamon Dennis J.¹,Clark Gary M.²,Wong Steven G.¹,Levin Wendy J.¹,Ullrich Axel³,McGuire William L.²

Affiliation:

1. Division of Hematology-Oncology, Department of Medicine and Jonsson Comprehensive Cancer Center, UCLA School of Medicine, Los Angeles, CA 90024.

2. Division of Oncology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78284.

3. Department of Molecular Biology, Genentech, Inc., South San Francisco, CA 94080.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference44 articles.

1. BARGMANN, C.I., MULTIPLE INDEPENDENT ACTIVATIONS OF THE NEU ONCOGENE BY A POINT MUTATION ALTERING THE TRANSMEMBRANE DOMAIN OF P185, CELL 45: 649 (1986).

2. BISHOP, J.M., CELLULAR ONCOGENES AND RETROVIRUSES, ANNUAL REVIEW OF BIOCHEMISTRY 52: 301 (1983).

3. BRESLOW, N.E., ANALYSIS OF SURVIVAL DATA UNDER PROPORTIONAL HAZARDS MODEL, INTERNATIONAL STATISTICAL REVIEW 43: 45 (1975).

4. Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease Stage

5. CAMPISI, J, CELL 33: 357 (1983).

Cited by 10111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neratinib plus dasatinib is highly synergistic in HER2-positive breast cancer in vitro and in vivo;Translational Oncology;2024-11

2. Targeted HER2-positive cancer therapy using ADAPT6 fused to horseradish peroxidase;New Biotechnology;2024-11

3. 177Lu-labeling of nuclear localization sequence (NLS)-grafted HER2-receptor affine peptide;Bioorganic & Medicinal Chemistry;2024-10

4. Dry eye disease adverse reaction of pharmacological treatment for early-stage breast cancer;The Ocular Surface;2024-10

5. Synthetic routes and clinical application of Small-Molecule HER2 inhibitors for cancer therapy;Bioorganic Chemistry;2024-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3